Invention Grant
- Patent Title: Fused heterocyclic compounds useful as kinase modulators
- Patent Title (中): 用作激酶调节剂的稠合杂环化合物
-
Application No.: US13055601Application Date: 2009-07-23
-
Publication No.: US08476430B2Publication Date: 2013-07-02
- Inventor: Chunjian Liu , Katerina Leftheris , Andrew J. Tebben
- Applicant: Chunjian Liu , Katerina Leftheris , Andrew J. Tebben
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Hong Liu; Gary D. Greenblatt
- International Application: PCT/US2009/051536 WO 20090723
- International Announcement: WO2010/011837 WO 20100128
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/53 ; A61P19/02
Abstract:
Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are useful as kinase modulators, including Btk modulation, wherein R1, R2, R3, R4, Q, A and B are as defined herein.
Public/Granted literature
- US20110124640A1 FUSED HETEROCYCLIC COMPOUNDS USEFUL AS KINASE MODULATORS Public/Granted day:2011-05-26
Information query
